The effect of systemically administered PDGF-BB on the rodent skeleton

Area of Science:

• Bone biology and regenerative medicine
• Endocrinology and metabolic bone diseases

Background:

• Platelet-Derived Growth Factor (PDGF) accelerates bone repair locally.
• Estrogen deficiency leads to bone loss, a common issue in osteoporosis.

Purpose of the Study:

• To investigate the systemic effects of PDGF on bone formation in intact bone.
• To evaluate PDGF's efficacy in estrogen-deficient rats, with and without an antiresorptive agent.

Main Methods:

• Systemic intravenous administration of PDGF and alendronate in ovariectomized (OVX) rats over 6 weeks.
• Dual-energy X-ray absorptiometry (DXA) for bone mineral density (BMD) assessment.
• Histomorphometry and biomechanical testing for bone structure and strength analysis.

Main Results:

• PDGF prevented bone loss and increased spinal and whole-skeleton BMD in OVX rats.
• Combined PDGF and alendronate treatment yielded superior increases in BMD and bone strength.
• PDGF increased osteoblast numbers and improved vertebral and femoral bone strength.

Conclusions:

• Systemic PDGF administration effectively increases bone density and strength throughout the skeleton.
• Combination therapy with alendronate potentiates the bone-building effects of PDGF.
• PDGF shows promise as a systemic treatment for bone loss conditions like osteoporosis.